Amivantamab 2.24g/14ml solution for injection vials

SNOMED code
45354311000001101
Active compound
Amivantamab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
14 ml, vial
Ingredients
Amivantamab — 160 mg / 1 ml based on ingredient substance
Form & Route
solutioninjection.subcutaneous
Solution for injection, Subcutaneous
Controlled drug
No Controlled Drug Status

Products

Rybrevant 2240mg/14ml solution for injection vials (Janssen-Cilag Ltd)

Rybrevant 2240mg/14ml solution for injection vials

SNOMED code
45346311000001105
Supplier
Janssen-Cilag Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Subcutaneous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Rybrevant 2240mg/14ml solution for injection vials (Janssen-Cilag Ltd) 1 vial
45346411000001103   ref. pack
💯 Available

Legal category: POM
05012674089163
5012674089163
NHS Indicative Price
£4,316
• Hospital
  • • Prescription Charges

Reference packs

Amivantamab 2.24g/14ml solution for injection vials 1 vial
SNOMED code
45346211000001102
Quantity and unit
1 vial
Packs